Medical Devices Analyst Jennings, along with Dr. Thomas, Neurosurgeon at Atlantic Neurosurgical & Spine Specialists discuss the proposed merger between NUVA and GMED on an Analyst/Industry conference call to be held on April 5 at 10:30 am. Webcast Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on NUVA:
- Canaccord upgrades Globus Medical with merger uncertainty priced in
- NuVasive gets FDA 510(k) clearance for Precice limb lengthening solution
- NuVasive Announces Fourth Quarter and Full-Year 2022 Financial Results and 2023 Net Sales Guidance
- NuVasive reports Q4 non-GAAP EPS 43c, consensus 51c
- Globus Medical price target lowered to $75 from $82 at Barclays